201 related articles for article (PubMed ID: 19409669)
1. [Hypertension, HIV infection, and highly active antiretroviral therapy].
Bernardino de la Serna JI; Zamora FX; Montes ML; García-Puig J; Arribas JR
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):32-7. PubMed ID: 19409669
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic disturbances associated with HAART].
Olczak A
Przegl Epidemiol; 2007; 61(4):639-46. PubMed ID: 18572495
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular risk factors associated with antiretroviral therapy].
Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidaemia associated with the highly active antiretroviral therapy in AIDS patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir).
Domingos H; da Cunha RV; Paniago AM
Braz J Infect Dis; 2007 Apr; 11(2):290-2. PubMed ID: 17625780
[TBL] [Abstract][Full Text] [Related]
5. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.
Francisci D; Giannini S; Baldelli F; Leone M; Belfiori B; Guglielmini G; Malincarne L; Gresele P
AIDS; 2009 Mar; 23(5):589-96. PubMed ID: 19177019
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
Bradbury RA; Samaras K
Diabetes Obes Metab; 2008 Jun; 10(6):441-50. PubMed ID: 17825081
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
Leonard EG; McComsey GA
Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.
Bergersen BM; Sandvik L; Dunlop O; Birkeland K; Bruun JN
Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):731-6. PubMed ID: 14610658
[TBL] [Abstract][Full Text] [Related]
9. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
10. [HAART influences the lipids].
Behrens G
MMW Fortschr Med; 2009 Apr; 151(18):36-8. PubMed ID: 19769073
[No Abstract] [Full Text] [Related]
11. Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients.
Domingos H; Cunha RV; Paniago AM; Martins DM; Elkhoury EB; Souza AS
Braz J Infect Dis; 2009 Apr; 13(2):130-6. PubMed ID: 20140358
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
[TBL] [Abstract][Full Text] [Related]
13. Getting to the HAART of insulin resistance.
Nolan D; Mallal S
AIDS; 2001 Oct; 15(15):2037-41. PubMed ID: 11600834
[No Abstract] [Full Text] [Related]
14. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.
Cahn P; Leite O; Rosales A; Cabello R; Alvarez CA; Seas C; Carcamo C; Cure-Bolt N; L'Italien GP; Mantilla P; Deibis L; Zala C; Suffert T
Braz J Infect Dis; 2010; 14(2):158-66. PubMed ID: 20563442
[TBL] [Abstract][Full Text] [Related]
17. [The side effects of antiretroviral therapy].
Hartmann M
Hautarzt; 2006 Nov; 57(11):969-74. PubMed ID: 17036249
[TBL] [Abstract][Full Text] [Related]
18. Dyslipidemia related to antiretroviral therapy.
Estrada V; Portilla J
AIDS Rev; 2011; 13(1):49-56. PubMed ID: 21412389
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated dyslipidaemia among HIV antibody-positive patients in Ireland: prevalence and management strategies.
Nolan DP; O'Connor MB; O'Connor C; Moriarty M; O'Leary A; Bergin C
Int J STD AIDS; 2010 Jan; 21(1):75-6. PubMed ID: 19884356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
